X
Beyond Air, Inc.
XAIRCIK 0001641631NasdaqNon-AcceleratedSmaller ReportingSurgical & Medical Instruments & ApparatusDelawareFY ends Mar 31
Period
FY 2026
Revenue
$7.68M
Net Income
$-33.25M
Total Assets
$35.38M
Equity
$6.13M
Shares Out
14.41M
Op. Cash Flow
$-18.10M
Business
Beyond Air, Inc. is a commercial-stage medical device and biopharmaceutical company developing nitric oxide generators and delivery systems under the LungFit® platform. LungFit® PH received FDA premarket approval in June 2022 for persistent pulmonary hypertension of the newborn and CE mark in November 2024. The company is developing LungFit® PRO for lung infections and LungFit® GO for nontuberculous mycobacteria, while maintaining majority-owned affiliates focused on oncology and neurological conditions. Beyond Air markets LungFit® PH directly in the U.S. and through distribution partners internationally.
Summary from 10-K filed 2026-06-26
Financials
Consolidated Statement of Income
Year Ended · In millions, except per-share amounts
| Concept | Trend | FY 2026 2026-03-31 | FY 2025 2025-03-31 | FY 2024 2024-03-31 | FY 2023 2023-03-31 | FY 2022 2022-03-31 |
|---|---|---|---|---|---|---|
| Revenues | 8 | 4 | 1 | — | — | |
| Cost of revenues | 7 | 5 | −2 | −555,000 | — | |
| Gross profit (loss) | 252,000 | −2 | −1 | −555,000 | — | |
| Research and development | 10 | 17 | −24 | −17 | −12 | |
| Selling, general and administrative | 19 | 26 | −37 | — | — | |
| Total operating expenses | 29 | 43 | −62 | −52 | −41 | |
| Loss from operations | −29 | −45 | −63 | −52 | −41 | |
| Dividend/investment income | 303,000 | 705,000 | — | — | — | |
| Interest and finance expense | −4 | −3 | −3 | — | — | |
| Change in fair value of warrant liability | 35,000 | 237,000 | 611,000 | — | — | |
| Change in fair value of derivative liability | −1 | 1 | 48,000 | — | — | |
| Foreign exchange loss | −108,000 | −3,000 | −6,000 | −105,000 | −144,000 | |
| Loss on extinguishment of debt | −165,000 | −2 | — | — | — | |
| Loss on disposal/impairment of fixed assets | −431,000 | −738,000 | — | — | — | |
| Other income/(expense) | −14,000 | 9,000 | −169,000 | — | — | |
| Total other income/(expense) | −5 | −4 | −1 | −7 | −3 | |
| Loss before income taxes | −34 | −48 | −64 | −59 | −44 | |
| Provision for income taxes | — | — | — | — | — | |
| Net loss | −34 | −48 | −64 | −59 | −44 | |
| Less: net loss attributable to non-controlling interest | −1 | −2 | −4 | −4 | −882,000 | |
| Net loss attributable to Beyond Air, Inc. | −33 | −47 | −60 | −56 | −43 | |
| Foreign currency translation adjustment | 194,000 | −45,000 | −68,000 | −43,000 | 96,000 | |
| Comprehensive loss attributable to Beyond Air, Inc. | −33 | −47 | — | — | — | |
| Net basic loss per share attributable to Beyond Air, Inc. | −4.01 | −13.77 | −1.82 | −1.86 | −1.68 | |
| Net diluted loss per share attributable to Beyond Air, Inc. | −4.01 | −13.77 | −1.82 | −1.86 | — | |
| Weighted average number of shares of common stock outstanding - basic | 8 | 3 | 33 | 30 | 26 | |
| Weighted average number of shares of common stock outstanding - diluted | 8 | 3 | 33 | 30 | — |
Consolidated Balance Sheet
As of · In millions, except per-share amounts
| Concept | Trend | FY 2026 2026-03-31 | FY 2025 2025-03-31 | FY 2024 2024-03-31 | FY 2023 2023-03-31 | FY 2022 2022-03-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 7 | 5 | 11 | 29 | 80 | |
| Marketable securities | 5 | 2 | 23 | 17 | — | |
| Restricted cash | 6 | 231,000 | 230,000 | 8 | 10 | |
| Accounts receivable, net | 1 | 710,000 | 319,000 | — | — | |
| Inventory, net | 1 | 2 | 2 | 1 | 350,000 | |
| Other current assets and prepaid expenses | 5 | 6 | 7 | 4 | 2 | |
| Total current assets | 25 | 16 | 44 | 59 | 93 | |
| Licensed right to use technology | 1 | 1 | 1 | 2 | — | |
| Right-of-use lease assets | 1 | 2 | 2 | 2 | 2 | |
| Property and equipment, net | 8 | 11 | 9 | 5 | 2 | |
| Other assets | 158,000 | 103,000 | 113,000 | 212,000 | 207,000 | |
| TOTAL ASSETS | 35 | 30 | 57 | 69 | 99 | |
| Accounts payable | 2 | 2 | 2 | 2 | 1 | |
| Accrued expenses and other current liabilities | 3 | 2 | 8 | — | — | |
| Operating lease liabilities, current portion | 321,000 | 396,000 | 418,000 | 376,000 | 281,000 | |
| Loans payable, current portion | 401,000 | 609,000 | 800,000 | 775,000 | 927,000 | |
| Total current liabilities | 7 | 5 | 12 | 20 | 11 | |
| Operating lease liabilities, net | 1 | 1 | 2 | 2 | 2 | |
| Long-term debt, net | 22 | 9 | 15 | 120,000 | 200,000 | |
| Warrant liability | 2,000 | 38,000 | 275,000 | — | — | |
| Total liabilities | 29 | 16 | 30 | 27 | 21 | |
| Commitments and contingencies (Note 12) | — | — | — | — | — | |
| Preferred Stock, $0.0001 par value per share: 10,000,000 shares authorized, 0 shares issued and outstanding | — | — | — | — | — | |
| Common Stock, $0.0001 par value per share: 500,000,000 shares authorized, 11,792,684 and 4,128,539 shares issued and outstanding as of March 31, 2026 and 2025, respectively | 1,000 | — | 5,000 | 3,000 | 3,000 | |
| Treasury stock | −25,000 | −25,000 | −25,000 | −25,000 | −25,000 | |
| Additional paid-in capital | 326 | 300 | 265 | 217 | 196 | |
| Accumulated deficit | −320 | −286 | −240 | −179 | −124 | |
| Accumulated other comprehensive income/(loss) | 134,000 | −60,000 | −15,000 | 53,000 | 96,000 | |
| Total stockholders equity attributable to Beyond Air, Inc. | 6 | 14 | 25 | 38 | 73 | |
| Non-controlling interest | 84,000 | 758,000 | 2 | 4 | 6 | |
| Total stockholders equity | 6 | 14 | 27 | 42 | 78 | |
| TOTAL LIABILITIES AND STOCKHOLDERS EQUITY | 35 | 30 | 57 | 69 | 99 |
Consolidated Statement of Cash Flows
Year Ended · In millions, except per-share amounts
| Concept | Trend | FY 2026 2026-03-31 | FY 2025 2025-03-31 | FY 2024 2024-03-31 | FY 2023 2023-03-31 | FY 2022 2022-03-31 |
|---|---|---|---|---|---|---|
| Depreciation | 3 | 3 | 2 | 634,000 | — | |
| Stock-based compensation | 5 | 9 | 21 | 20 | 8 | |
| Amortization of debt discount and accretion of debt issuance costs | 551,000 | 1 | 1 | — | 528,000 | |
| Amortization of licensed right to use technology | 204,000 | 205,000 | 205,000 | 205,000 | 38,000 | |
| Amortization of operating lease assets | 398,000 | 367,000 | 372,000 | 331,000 | 236,000 | |
| Unrealized loss on marketable securities | — | 60,000 | 123,000 | −12,000 | — | |
| Provision for inventory losses | 672,000 | 177,000 | — | — | — | |
| Provision for bad debt | 91,000 | — | — | 49,000 | — | |
| Foreign currency adjustments | −119,000 | — | — | — | — | |
| Impairment of fixed assets | — | 505,000 | — | — | — | |
| Loss on disposal of fixed assets | 431,000 | 334,000 | 15,000 | — | — | |
| Paid in kind interest | 2 | 696,000 | — | — | — | |
| Inventory | 1 | −466,000 | −998,000 | −781,000 | — | |
| Accounts receivable | −468,000 | −390,000 | −319,000 | — | — | |
| Other current assets and prepaid expenses | 683,000 | 1 | −2 | 918,000 | −816,000 | |
| Accounts payable | 267,000 | 399,000 | −467,000 | 838,000 | −327,000 | |
| Accrued expenses | 1 | −6 | −13 | 5 | 5 | |
| Operating lease liabilities | −373,000 | −385,000 | −381,000 | −275,000 | — | |
| Net cash used in operating activities | −18 | −38 | −56 | −33 | −23 | |
| Purchase of marketable securities | −4 | −31 | — | −36 | — | |
| Proceeds from sale of marketable securities | 1 | 52 | 122 | 19 | — | |
| Security deposits made on operating leases | — | 10,000 | — | 1,000 | −69,000 | |
| Purchase of property and equipment | −1 | −6 | −6 | −4 | −1 | |
| Net cash (used in)/provided by investing activities | −4 | 15 | −12 | −21 | −1 | |
| Proceeds from issuance of common stock through at the market offerings, net | 8 | 2 | 13 | 4 | 36 | |
| Proceeds from the sale of common stock of NeuroNos | 700,000 | 2 | — | — | — | |
| Proceeds from issuance of common stock and pre-funded warrants through securities purchase, net | 5 | 19 | — | — | 25 | |
| Proceeds from issuance of common stock through exercise of warrants | 3 | 365,000 | — | — | 6 | |
| Proceeds from issuance of common stock warrants | 90,000 | — | — | — | — | |
| Proceeds from long term loan | 14 | 11 | 16 | — | — | |
| Debt issuance costs | −996,000 | — | — | — | — | |
| Payment of loan | −208,000 | −18 | −835,000 | −1 | −658,000 | |
| Net cash provided by financing activities | 29 | 17 | 43 | 3 | 79 | |
| Effect of exchange rate changes on cash and cash equivalents | 194,000 | −45,000 | −77,000 | −43,000 | 96,000 | |
| Increase/(decrease) in cash, cash equivalents and restricted cash | 7 | −7 | −25 | −51 | 55 | |
| Debt discount | 1 | 3 | 5 | — | — | |
| Derivative liability | 775,000 | — | −1 | — | — | |
| Short term finance liability | 457,000 | 693,000 | 740,000 | — | — | |
| Fixed assets recorded in accounts payable and accrued expenses | 398,000 | 396,000 | — | — | — | |
| Right-of-use assets acquired under operating leases | 139,000 | — | — | — | — | |
| Debt principal balance converted to equity | 1 | — | — | — | — | |
| Interest paid | 423,000 | 1 | 2 | 36,000 | 340,000 | |
| Income taxes paid | — | — | — | — | — |
Filings
Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro
Material Events
Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro
Insiders
Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro
Institutional Holders
Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro
Frequently asked questions
What is Beyond Air, Inc.'s CIK number?
Beyond Air, Inc.'s SEC CIK number is 0001641631 (1641631). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find Beyond Air, Inc.'s SEC filings?
All of Beyond Air, Inc.'s EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.
When did Beyond Air, Inc. last report earnings?
Beyond Air, Inc. (XAIR) most recently filed an earnings 8-K with the SEC on Jun 26, 2026, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0001493152-26-030305). This is Beyond Air, Inc.'s most recent earnings filing of record — not a forecast of its next earnings date.
What is Beyond Air, Inc.'s most recent earnings 8-K?
Beyond Air, Inc.'s latest earnings 8-K (Item 2.02) was filed Jun 26, 2026 under accession 0001493152-26-030305. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.
View Beyond Air, Inc.'s latest earnings 8-K →
Look up any company's CIK number →